New Product Development
[Report of 250 Pages] The market for softgel capsules is anticipated to reach a value of US$ 1.7 billion by the end of 2022 and to grow at a CAGR of 6.0% to reach US$ 3.1 billion by 2032. In 2021, gelatin softgel capsules will dominate the global market, with a share of about 75.3%, …
Continue reading “Softgel Capsules Market to reach a valuation of ~US$ 3.1 Billion by 2032”
[250 Pages Report] According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031. Ocular drug delivery systems are designed for dispensing drug, biologic, biopharmaceutical, and botanical …
Continue reading “Ocular Drug Delivery System Market sales will total US$ 27.82 Billion by 2031”
During the forecast period 2023-2033, the pituitary stalk interruption syndrome treatment market is expected to grow at a value of 3.5% CAGR, according to Future Market Insights. By the year 2033, the global market for pituitary stalk interruption syndrome treatment is expected to rise up to a market valuation of US$ 159.14 Million. Growth of the pituitary …
The power transformer market exhibited year-on-year growth of 4% in 2021, backed by increasing efforts towards incorporating modern energy solutions in existing power system and high demand of efficient and reliable power supply. Future Market Insights (FMI) states that, power transformer market revenue grew by 10% between 2019 and 2021, reaching US$ 21.9 billion in 2021 with …
Continue reading “Power Transformer Market Size, Share 2031: Present Scenario and Growth Prospects”
The global Rheumatic-Heart Disease Management market size is expected to be valued at US$ 1.31 Billion in 2023. With the continuous improvements in drugs and biotechnology, the overall demand for Rheumatic-Heart Disease Management is projected to grow at a CAGR of 4.5% between 2023 and 2033, totaling around US$ 2.04 Billion by 2033. The rising prevalence of cardiovascular diseases globally is one of the major …
In fiscal year 2023, the market for managing heterozygous familial hypercholesterolemia (HEFH) management is anticipated to be valued US$ 15.11 Billion, up from US$ 13.2 billion in fiscal year 2022. The worldwide market is anticipated to expand at a constant 14.5% CAGR from 2023 to 2033, reaching a value of US$ 58.54 Billion by the end of …
A recently published study by FMI expects the global PCSK9 inhibitors market to augment at a 15.8% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 13 Billion is expected for the market. Monoclonal antibodies are a kind of biologic medicine that inhibits PCSK9. PCSK9 inhibitors bind to and …
Continue reading “PCSK9 Inhibitors Sales to expand at a 15.8% CAGR from 2023 to 2033 | FMI Report”
The Global Generic Injectable market research report contains critical information about the global, regional, and top players, such as Generic Injectable market share analysis, winning strategies, recent developments, and financial planning. Aside from providing information about the key players in the Generic Injectable market, the study also recalculates the impact of macroeconomic and microeconomic factors …
According to a recent study published by Future Market Insights, the market for oncolytic virus cancer therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have captured steps to raise awareness about …
Continue reading “Oncolytic Virus Cancer Therapy Market growing at a whopping 27% CAGR: FMI Report”
The global mobile clinics market is expected to showcase a positive growth outlook of the global mobile clinics market by exhibiting a total CAGR of around 11.3% from 2022 to 2032. The global market is expected to enjoy a valuation of US$ 2.8 Bn by the end of the year 2022 and surpass a valuation of around …
Continue reading “Mobile Clinics Market to Surpass US$ 8.1 Billion Revenue by 2032 | FMI”
